Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER × Aggression × Clear all

Phase

Phase 2 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 441 Leukemia, Myeloid, Acute 416 Neoplasms 318 Carcinoma, Non-Small-Cell Lung 314 Pancreatic Neoplasms 279 Glioblastoma 275 Precursor Cell Lymphoblastic Leukemia-Lymphoma 266 Multiple Myeloma 266 Melanoma 257 Prostatic Neoplasms 252 Leukemia 244 Brain Neoplasms 243 Lymphoma 231 Neoplasm Metastasis 229 Recurrence 228 Lung Neoplasms 225 Ovarian Neoplasms 216 Lymphoma, Non-Hodgkin 210 Leukemia, Lymphocytic, Chronic, B-Cell 197 Colorectal Neoplasms 197 Glioma 182 Myelodysplastic Syndromes 176 Lymphoma, Large B-Cell, Diffuse 149 Carcinoma, Hepatocellular 148 Hodgkin Disease 140 Sarcoma 134 Lymphoma, Follicular 134 Head and Neck Neoplasms 133 Unspecified Adult Solid Tumor, Protocol Specific 131 Burkitt Lymphoma 126

Interventions

selinexor 1 Rituximab 1 Ifosfamide 1 Etoposide 1 Dexamethasone 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡